ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.842,21
-1,14%
S&P 500
5.732,16
-0,77%
Dow Jones
42.567,29
-0,05%
Euro vs US Dollar
1,07803
-0,06%
Bitcoin
86.951,96
-0,59%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Travere Therapeutics Inc (TVTX) Börsenkurse

Travere Therapeutics Inc

Travere Therapeutics Inc (TVTX)

NASDAQ
20,56
-0,45
( -2,14% )
Aktualisiert: 17:14:08
Verzögert um 15 Minuten
Fortg. Diagramm

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
20,56
Gebot
20,56
Fragen
20,62
Volumen
690.972
20,2896 Tagesbereich 21,28
5,12 52-Wochen-Bereich 25,29
Marktkapitalisierung
1,824B
Handelsende
21,01
Handelsbeginn
21,00
Letzte Trade
25
@
20.585
Letzter Handelszeitpunkt
17:14:08
Finanzvolumen
US$ 14.285.928
VWAP
20,6751
Durchschnittliches Volumen (3 Mio.)
1.620.577
Ausgegebene Aktien
88.739.826
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-5,63
Gewinn pro Aktie (EPS)
-3,62
Erlöse
233,18M
Nettogewinn
-321,55M

Über Travere Therapeutics Inc

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
travere.com
Hauptsitz
Lewes, Delaware, USA
Gegründet
-
Travere Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TVTX. The last closing price for Travere Therapeutics was US$21,01. Over the last year, Travere Therapeutics shares have traded in a share price range of US$ 5,12 to US$ 25,29.

Travere Therapeutics currently has 88.739.826 shares in issue. The market capitalisation of Travere Therapeutics is US$1,86 billion. Travere Therapeutics has a price to earnings ratio (PE ratio) of -5.63.

TVTX Neueste Nachrichten

Weitere Nachrichten

Form 8-K - Current report
Edgar (US Regulatory)
17 März 2025
TVTX (-2,14%)

Form 8-K - Current report
Edgar (US Regulatory)
20 Februar 2025
TVTX (-2,14%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.773.8908539666519.7921.3519.59173678020.770541CS
4-0.67-3.1559114460721.2321.9817.15158680319.88287844CS
122.8916.355404640617.6725.2916.8162057720.67040178CS
265.8539.768864717914.7125.2913.24160239718.78278506CS
5212.7161.5776081427.8625.295.12145524414.26047599CS
156-5.02-19.624706802225.5830.355.12127552015.35045213CS
260-4.59-18.250497017925.1533.08995.12110980116.88724292CS

TVTX - Frequently Asked Questions (FAQ)

What is the current Travere Therapeutics share price?
The current share price of Travere Therapeutics is US$ 20,56
How many Travere Therapeutics shares are in issue?
Travere Therapeutics has 88.739.826 shares in issue
What is the market cap of Travere Therapeutics?
The market capitalisation of Travere Therapeutics is USD 1,86B
What is the 1 year trading range for Travere Therapeutics share price?
Travere Therapeutics has traded in the range of US$ 5,12 to US$ 25,29 during the past year
What is the PE ratio of Travere Therapeutics?
The price to earnings ratio of Travere Therapeutics is -5,63
What is the cash to sales ratio of Travere Therapeutics?
The cash to sales ratio of Travere Therapeutics is 7,77
What is the reporting currency for Travere Therapeutics?
Travere Therapeutics reports financial results in USD
What is the latest annual turnover for Travere Therapeutics?
The latest annual turnover of Travere Therapeutics is USD 233,18M
What is the latest annual profit for Travere Therapeutics?
The latest annual profit of Travere Therapeutics is USD -321,55M
What is the registered address of Travere Therapeutics?
The registered address for Travere Therapeutics is 16192 COASTAL HWY, LEWES, DELAWARE, 19958
What is the Travere Therapeutics website address?
The website address for Travere Therapeutics is travere.com
Which industry sector does Travere Therapeutics operate in?
Travere Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PTPIPetros Pharmaceuticals Inc
US$ 0,17869
(209,15%)
1,11B
OSRHOSR Holdings Inc
US$ 3,10
(93,75%)
64,51M
VVPRVivoPower International PLC
US$ 4,1399
(83,18%)
120,57M
OCEAOcean Biomedical Inc
US$ 0,1033
(81,87%)
296,47M
SURGSurgePays Inc
US$ 2,065
(49,64%)
60,55M
BACKIMAC Holdings Inc
US$ 0,072
(-64,00%)
1,08M
ACRVAcrivon Therapeutics Inc
US$ 3,31
(-38,59%)
831,73k
TNONTenon Medical Inc
US$ 2,46
(-34,40%)
15,57M
HUMAHumacyte Inc
US$ 2,025
(-29,57%)
14,6M
ICGIntchains Group Ltd
US$ 3,0085
(-26,98%)
105,06k
PTPIPetros Pharmaceuticals Inc
US$ 0,17869
(209,15%)
1,11B
OCEAOcean Biomedical Inc
US$ 0,1033
(81,87%)
296,47M
LYTLytus Technologies Holdings PTV Ltd
US$ 0,066
(30,43%)
147,04M
NVDANVIDIA Corporation
US$ 113,8851
(-5,64%)
144,18M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,635
(-10,25%)
128,08M

TVTX Finanzen

Finanzen

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
TVTX
Travere Therapeutics
BMF
DITF27
DITF27 - 01/2027
NASDAQ
MNTX
Manitex
USOTC
VYSNF
Vysarn (PK)
NASDAQ
BBLG
Bone Biologics
NASDAQ
FNCH
Finch Therapeutics
Delayed Upgrade Clock
ADVFN Logo
Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten